APA (7th ed.) Citation

A, B., A, L., A, B., F, L., E, G., A, C., . . . L, C. (2023). Clinical utility of checkpoint inhibitors against metastatic bladder cancer: Overcoming challenges to find a way forward. Expert opinion on biological therapy, 23(5), 407. https://doi.org/10.1080/14712598.2023.2201371

Chicago Style (17th ed.) Citation

A, Bilé-Silva, Lopez-Beltran A, Blanca A, Lopez-Rios F, Gómez-Gómez E, Cimadamore A, Montironi R, Vau N, and Cheng L. "Clinical Utility of Checkpoint Inhibitors Against Metastatic Bladder Cancer: Overcoming Challenges to Find a Way Forward." Expert Opinion on Biological Therapy 23, no. 5 (2023): 407. https://doi.org/10.1080/14712598.2023.2201371.

MLA (9th ed.) Citation

A, Bilé-Silva, et al. "Clinical Utility of Checkpoint Inhibitors Against Metastatic Bladder Cancer: Overcoming Challenges to Find a Way Forward." Expert Opinion on Biological Therapy, vol. 23, no. 5, 2023, p. 407, https://doi.org/10.1080/14712598.2023.2201371.